Shanshan Guo

Shanshan Guo

Auto-generated profile, based on publicly available information

Shanshan Guo

Department of Nephrology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2021 in Frontiers in Human Neuroscience
Verified
Journal Article
Open access
PDF file
YWYujiao Wen
Yujiao Wen
XZXuemin Zhang
Xuemin Zhang
YXYifan Xu
Yifan Xu
DQDan Qiao
Dan Qiao
SGShanshan Guo
Shanshan Guo
ZLZhifen Liu
Zhifen Liu
The lifetime prevalence of major depressive disorder (MDD) in adolescents is reported to be as high as 20%; thus, MDD constitutes a significant social and public health burden. MDD is often associated with nonsuicidal self-injury (NSSI) behavior, but the contributing factors including cognitive function have not been investigated in detail. To this end, the present study evaluated cognitive impairment and psychosocial factors in associated with MDD with NSSI behavior. Eighteen and 21 drug-naïve patients with first-episode MDD with or without NSSI (NSSI+/– group) and 24 healthy control subjects (HC) were enrolled in the study. The Hamilton Anxiety Scale (HAMA), Hamilton Depression Scale (HAMD), Adolescent Self-injury Questionnaire, Beck Scale for Suicide Ideation–Chinese Version (BSI-CV), Shame Scale for Middle School Students, Sensation Seeking Scale (SSS) and Childhood Trauma Questionnaire (CTQ) were used to assess depression-related behaviors, and event-related potentials (ERPs) were recorded as a measure of cognitive function. The latency of the N1, N2, P3a, P3b, and P50 components of ERPs at the Cz electrode point; P50 amplitude and P50 inhibition (S1/S2) showed significant differences between the 3 groups. CTQ scores also differed across three groups, and the NSSI– and NSSI+ groups showed significant differences in scores on the Shame Scale for Middle School Students. Thus, cognitive function was impaired in adolescents with MDD with NSSI behavior, which was mainly manifested as memory decline, attention and executive function deficits, and low anti-interference ability. We also found that childhood abuse, lack of social support, and a sense of shame contributed to NSSI behavior. These findings provide insight into the risk factors for MDD with NSSI behavior, which can help mental health workers more effectively diagnose and treat these patients.

8 July 2023 in Environmental Science and Pollution Research
Verified
Journal Article
Closed access
PDF file
成杨成 杨
成 杨
HZHan Zhang
Han Zhang
YFYuanyuan Feng
Yuanyuan Feng
YHYuansi Hu
Yuansi Hu
SCSikai Chen
Sikai Chen
ZZZhuo Zeng
Zhuo Zeng

24 August 2023 in International Immunopharmacology
Verified
Journal Article
Closed access
HWHuaying Wang
Huaying Wang
SGShanshan Guo
Shanshan Guo
WBwang bingdian
wang bingdian
XLXueqi Liu
Xueqi Liu
LGLi Gao
Li Gao
YWYonggui Wu
Yonggui Wu

27 October 2023 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
DLDan Li
Dan Li
JWJuan Wang
Juan Wang
LZLiuyang Zhao
Liuyang Zhao
JYJie Yan
Jie Yan
YZYu-Cong Zou
Yu-Cong Zou
YWYulong Wang
Yulong Wang

1 April 2019 in Chemical Physics Letters
Verified
Journal Article
Closed access
SGShanshan Guo
Shanshan Guo
XYXiaolian Yan
Xiaolian Yan
ZLZhongxu Luo
Zhongxu Luo
MDMinlong Ding
Minlong Ding
HLHaitao Liu
Haitao Liu
XYXinyu Yang
Xinyu Yang

3 February 2022 in Advances in Radiation Oncology
Verified
Journal Article
Open access
ZYZhen-Chong Yang
Zhen-Chong Yang
CDChao-Chao Du
Chao-Chao Du
LLLi-Ting Liu
Li-Ting Liu
YLYu-Jing Liang
Yu-Jing Liang
LTLin-Quan Tang
Lin-Quan Tang
SGShan-Shan Guo
Shan-Shan Guo
Our purpose was to investigate the prognostic role of plasma Epstein-Barr virus (EBV) DNA levels in the middle of intensity modulated radiation therapy (IMRT). In total, 1881 patients with stage III-IVa tumors were included. The overall survival (OS) and progression-free survival (PFS) were calculated using the Kaplan-Meier method, and the differences were compared using the log-rank test. Receiver operating characteristic curve analysis was performed to analyze the diagnostic value of EBV DNA levels for tumor progression or death. Multivariate analyses using the Cox model were used to evaluate potential prognostic factors. The positive predict value and negative predict value of plasma EBV DNA > 0 copies/mL in the middle of IMRT in predicting nasopharyngeal carcinoma progression was 37.4% and 85.5%, respectively. In patients with plasma EBV DNA level = 0 copies/mL, no significant differences in OS were observed between patients treated with 200 mg/m² cisplatin and those treated with >200 mg/m² cisplatin (5-year OS, 94.9% vs 94.4%; PFS, 81.5% vs 87.6%). However, those treated with >200 mg/m² cisplatin had higher PFS. In patients with plasma EBV DNA level > 0 copies/mL, patients treated with >200 mg/m² cisplatin displayed a favorable 5-year OS (84.6% vs 73.9%) and PFS (72.3% vs 54.8%) compared with those treated with 200 mg/m² cisplatin. Additionally, higher incidences of grade 3 and 4 adverse events were recorded in patients treated with >200 mg/m² cisplatin than in those treated with 200 mg/m² cisplatin. Plasma EBV DNA > 0 copies/mL in the middle of IMRT suggests that higher doses of chemotherapy should be used. For concurrent chemoradiation therapy, >200 mg/m² cisplatin is recommended for patients with plasma EBV DNA level > 0 copies/mL in the middle of IMRT but not for patients with plasma EBV DNA level = 0 copies/mL considering the similar OS rates.